NCT02513901View on ClinicalTrials.gov

Chidamide in Combination With Antiretroviral Therapy for Eradication of the Latent HIV-1 Reservoir

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Chronic HIV Infections
Interventions
DRUG

Chidamide

Chidamide will be given by mouth on Day 0, 3, 7, 10, 14, 17, 21, 24.

Trial Locations (1)

710038

Department of Infectious Diseases, Tangdu Hospital, The Fourth Military Medical University, Xi'an

Sponsors
All Listed Sponsors
collaborator

Chipscreen Biosciences, Ltd.

INDUSTRY

lead

Tang-Du Hospital

OTHER